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The multidrug-resistant bacteria have become a serious problem to public health. In this scenery the
antimicrobial peptides (AMPs) derived from animals and plants emerge as a novel therapeutic modality,
substituting or in addition to the conventional antimicrobial. The anurans are one of the richest natural
sources of AMPs. In this work several cycles of cDNA cloning of the skin of the Brazilian treefrog Hyp-
siboas semilineatus led to isolation of a precursor sequence that encodes a new AMP. The sequence
comprises a 27 residue signal peptide, followed by an acidic intervening sequence that ends in the
mature peptide at the carboxy terminal. The AMP, named Hs-1, has 20 amino acids residues, mostly
arranged in an alpha helix and with a molecular weight of 2144.6 Da. The chemically synthesized Hs-1
showed an antimicrobial activity against all Gram-positive bacteria tested, with a range of 11e46 mM, but
it did not show any effect against Gram-negative bacteria, which suggest that Hs-1 may have a selective
action for Gram-positive bacteria. The effects of Hs-1 on bacterial cells were also demonstrated by
transmission electron microscopy. Hs-1 is the ﬁrst AMP to be described from H. semilineatus.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
The emergence of multiple drug-resistant strains of pathogenic
bacteria has become a serious problem to public health that re-
quires novel therapeutic modalities. Most conventional antibiotics
act by interfering in a speciﬁc manner with bacteria homeostasis,
which requires a period of few days for disabling. These mecha-
nisms inhibit process that is not only essential for bacterial growth
but also introduces extreme selection pressure for resistant bacte-
ria (Smith and Romesberg, 2007). Besides, under such circum-
stances the bacteria morphology is normally preserved and a
bacterium that is initially sensitive to the drug can develop resis-
tance through mechanisms such as preventing the antibiotic from
binding or entering the organism and producing an enzyme that
inactivates the antibiotic or remodeling target molecules (Stark
et al., 2002).a).As substitutes or in addition to the currently used antimicrobial
compounds the antimicrobial peptides (AMPs) derived from ani-
mals and plants have been widely researched. These peptides are
part of the innate immune system of the organisms and represent
the ﬁrst-line of defense against invading pathogens, which is one of
the most ancient and efﬁcient components of host defense. Unlike
traditional antibiotic agents, most of the AMPs kill microorganisms
rapidly by disrupting and permeating the microbial membrane
(Dathe et al., 2002), which is a mechanism that prevents a target
organism from developing resistance to the peptide because the
membrane redesign is probably a “costly” and improbable solution
for most microbial species (Zasloff, 2002).
The dorsal skin of anurans is one of the richest natural sources of
broad-spectrum AMPs (Rinaldi, 2002), which defend the naked
skin against invasion by pathogenic microorganisms and protect
from ingestion by predators. The anurans dermal granular glands
synthesize and expel an extensive spectrum of bioactive molecules
such as neuropeptides, alkaloids, proteins, biogenic amines and
huge amounts of AMPs in response to stress or injury (Lazarus and
Attila, 1993). As a rule, a given anuran species produces a unique
L. Nacif-Marçal et al. / Toxicon 99 (2015) 16e22 17repertoire of AMPs, which is composed of peptides with different
sizes, sequences, charges, hydrophobicity, three-dimensional (3D)
structures, and spectrum of action (Charpentier et al., 1998; Nicolas
et al., 2003; Vanhoye et al., 2003).
The AMPs of South American frogs from Hylidae family are
derived from precursors whose amino terminal are highly
conserved, but the carboxyl terminal domains, which correspond to
mature peptides, are strongly diverse (Vanhoye et al., 2003). The
conserved region contains a hydrophobic signal peptide, followed
by an acidic propiece that ends by a typical prohormone processing
signal LyseArg and a C-terminal AMP-encoding domain (Nicolas
et al., 2003; Vanhoye et al., 2003).
Molecular cloning of Hylidae frog cDNAs can be performed to
identify and isolate new AMPs. Therefore, the aim of our study was
to identify AMPs from the skin of the Brazilian frog Hypsiboas
semilineatus (Spix, 1824) (Amphibia, Anura, Hylidae) (Frost, 2013)
that has never been researched before. We have reported here the
molecular cloning of cDNAs encoding AMPs precursors in
H. semilineatus and the structural and functional analysis of the new
discovered AMP named Hs-1.
2. Materials and methods
2.1. Animal
We used two specimens of H. semilineatus in this study. The
frogs were captured from the forest fragments of Viçosa city by a
specialized team of Jo~ao Moojen Museum of Zoology of the Federal
University of Viçosa, Brazil, according to the Brazilian Environ-
mental Agency (IBAMA e Instituto Brasileiro do Meio Ambiente e
dos Recursos Naturais Renovaveis) under the license 10504-1.
2.2. Bacterial strains
The references strains of bacteria used in the biological assays
are from the American Type Culture Collection (ATCC; Rockville,
MD, USA) and include the Gram-positive bacteria methicillin-
resistant Staphylococcus aureus (ATCC 33591), Bacillus cereus
(ATCC 14579), Bacillus subtilis (ATCC 23858), Listeria monocytogenes
(ATCC 7644) and the Gram-negative bacteria Citrobacter freundii
(ATCC 8090), Enterobacter sakazakii (ATCC 29004), Escherichia coli
(ATCC 29214), Moraxella catarrhalis (ATCC 25238), Proteus vulgaris
(ATCC 13315), Salmonella enterica (ATCC 14028) and Shigella ﬂexneri
(ATCC 12022).
2.3. Screening of cDNAs encoding AMPs
After capturing them, the specimens were immediately eutha-
nized by lethal injections of xylocaine in the ventral region. The
specimens were processed in two independent experiments. The
dorsal skins were removed surgically and homogenized in TRIzol
reagent (Invitrogen). Total RNA was isolated directly from the skin
homogenate and cDNA was synthesized using the enzyme M-MLV
reverse transcriptase (SIGMA) and an oligo(dT)-anchor primer (50-
GACCACGCGTATCGATGTCGACTTTTTTTTTTTTTTTTT-30). The cDNA
ampliﬁcation reactions employed a degenerate 50-primer (50-
ATGGCTTTCCTGAARAARTCBCTTTTY-30) that was designed based
on the highly conserved 50-signal regions of previously character-
ized AMPs cDNAs of anurans of Hylidae's family, and the 30-anchor
primer. Polymerase chain reaction (PCR) cycling procedures were
performed as follows: initial denaturation of 94 C for 300 s, 35
cycles of 94 C for 60 s, 56 C for 45 s, 72 C for 60 s and one cycle of
72 C for 10 min. The PCR products were gel-puriﬁed using a
Wizard SV Gel and PCR Clean-up System (Promega) and they were
cloned using the InsTAclone PCR Cloning Kit (Fermentas) and usedto transform competent TOP10 E. coli. The transformants were
ampliﬁed with universal M13 primers, the plasmids of the positive
clones were extracted with PureYield Plasmid Midiprep System
(Promega), and both the strands of the plasmids were sequenced
(Macrogen, Korea). The amino acids sequences were deduced from
cDNAs sequences and PEPTIDES 2.0 (USA) chemically synthesized
the corresponding peptide of interest. Prior to biological tests, the
lyophilized peptide was diluted in a solution of 50% Dimethyl
sulfoxide (DMSO) to a 1 mg/mL ﬁnal concentration.
2.4. Antimicrobial assays
Minimum inhibitory concentration (MIC) of synthetic Hs-1 were
determined by a standard microdilution method (Ferraro and
Wikler, 2009) using 96-well microtiter cell-culture plates and
were taken as the lowest concentration of peptide where no visible
growth was observed. Serial dilutions of the peptide in Muel-
lereHinton broth (50 mL) were mixed with an inoculum (50 mL of
106 CFU/mL) from a log-phase culture of reference strains from
ATCC. The bacteria were incubated aerobically for 20 h at 37 C and
the absorbance at 600 nm of each well was determined using a
microtiter plate reader. Serial dilutions of the broad-spectrum
antibiotic gentamicin and of 50% DMSO were used as controls for
the antimicrobial assays. The experiments were performed three
times with triplicates.
2.5. Cytolytic assays
The cytotoxicity of the peptide was evaluated in human eryth-
rocytes and in leukocytes from a healthy donor. The blood was
collected in citrate buffer 3.8% (pH 7.4) and separated by centrifu-
gation. To determine the hemolytic activity, serial dilutions of the
peptide Hs-1 in 0.85% saline (50 mL) were incubated with a 2%
suspension of erythrocytes (50 mL) in wells of U-shaped bottom
plates and incubated for 24 h at room temperature. The absorbance
of the supernatant was measured at 450 nm. To evaluate the
cytotoxicity of the peptide in nucleated cells, 1  105 leukocytes
were exposed to serial dilutions of the peptide in Roswell Park
Memorial Institute medium (RPMI) 1640 and incubated for 24 h at
37 C. The leukocyte's viability was measured by 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
method (Levitz and Diamond, 1985). A parallel incubation in the
presence of 1% v/v Triton X-100 and saline or RPMI medium were
used as controls to determine the absorbance associated with
respectively 100% and 0% of cytolysis, respectively. The cytotoxicity
of 50% DMSO was also measured. The median toxic dose (LC50)
value was taken as the mean concentration of peptide producing
50% of cytolysis (Conlon et al., 2007a, 2008). To assess selectivity of
the peptide, we calculated its therapeutic index (TI ¼ LC50/MIC)
(Y Chen et al., 2005; Conlon et al., 2008). The experiments were
performed three times with triplicates.
2.6. Structural and physiochemical analysis of Hs-1
The prediction of the secondary structure of Hs-1 was per-
formed using the self-optimized predictionmethodwith alignment
(SOPMA) method (Combet et al., 2000) and the PEP-FOLD server.
The 3D schematic representations were visualized with Jmol
(www.jmol.org). The two-dimensional projection of the amino
acids in the alpha helix was visualized by the SchiffereEdmundson
helical wheel projection (Schiffer and Edmundson, 1967). The
peptide parameters, including theoretical molecular weight, pI, net
charge and grand average of hydropathicity (GRAVY) were
computed by ProtParam (http://web.expasy.org/cgi-bin/
protparam/protparam). The thermal stability of the antimicrobial
Table 1
Minimum inhibitory concentration (MIC) against Gram-positive and Gram-
negative bacteria of the synthetic peptide Hs-1 identiﬁed from the skin of the
frog H. semilineatus.
Microorganisms Hs-1 MIC (mM)
Gram-positive bateria
Staphylococcus aureus ATCC 33591 11.7
Bacillus cereus ATCC 14579 23.3
Bacillus subtilis ATCC 23858 23.3
Listeria monocytogenes ATCC 7644 46.6
Gram-negative bacteria
Citrobacter freundii ATCC 8090 NA
Enterobacter sakazakii ATCC 29004 NA
Escherichia coli ATCC 29214 NA
Moraxella catarrhalis ATCC 25238 NA
Proteus vulgaris ATCC 13315 NA
Salmonella enterica ATCC 14028 NA
Shigella ﬂexneri ATCC 12022 NA
NA e not active at 187 mM (400 mg/mL).
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MuellereHinton broth was pre-incubated at various temperatures
(50, 60, 70, 80, 90 e 100 C) and cooled before it was incubation
with an inoculum (5  104 colony forming unit (CFU)) from a log-
phase culture of S. aureus (ATCC 33591). Bacteria were incubated
aerobically for 20 h at 37 C, and the absorbance at 600 nm of each
well was determined using a microtiter plate reader. A parallel
incubation of Hs-1 at room temperature was used as control to
check for its 100% antimicrobial activity (full activity).
2.7. Transmission electron microscopy (TEM)
The effects of the interaction between Hs-1 and bacteria were
observed from the incubation of 5  104 CFU of S. aureus (ATCC
33591) with 200 mg/mL of synthetic Hs-1 for 2 h and 3 h at 37 C,
followed by observation under TEM, which was performed under
standard operating conditions following negative staining with 2%
uracil in a Zeiss EM 109 transmission electron microscope. Cultures
without peptides were used as negative control. S. aureus (ATCC
33591) was chosen as the standard strain for microscopy as it is the
most sensitive strain to Hs-1. The TEM was performed in three
independent experiments.
3. Results
3.1. Cloning of AMPs cDNAs
To screening the possible sequences of cDNA coding for AMPs,
we used degenerate primers complementary to the highly
conserved region of the signal peptide of AMPs previously
sequenced from other Hylidae's frog. The agarose gel analysis of the
cDNA ampliﬁcation showed a large band of 300e400 base pairs
(data not shown). Following several rounds of cloning and cDNA
sequencing, one novel peptide precursor sequence was successfully
obtained. The deduced amino acid sequence of the cDNA encoding
the putative peptide included an N-terminal region encompassing
27 residues of the signal peptide, followed by an acidic region
containing several glutamic acid residues that terminates in a sin-
gle copy of the mature AMP at the C-terminal. A typical LyseArg
(-KR-) cutting site for trypsin-like proteases, which is responsible
for cleavage and release of the mature peptide, is located between
acidic region and mature peptide (Fig. 1). An NCBI-Blast and AMP
database research revealed that this peptide, named Hs-1, is a novel
and an unpublished AMP. The nucleotide sequence of Hs-1 was
deposited in GenBank under the accession number KF147143. The
sequence analysis of Hs-1 in online Antimicrobial Peptide Database
(http://aps.unmc.edu/AP/main.php) revealed high levels of
sequence similarity to other known AMPs of Phyllomedusa hypo-
chondrialis: 54.54% of similarity with Phylloseptin 12, Phylloseptin
H9 and Phylloseptin H10 (data not shown).Fig. 1. Nucleic and amino acid sequences of cDNA encoding the putative Hs-1 of Hypsiboa
sequence is in uppercase letters above the nucleotide sequence. Numbers on the right indica
line), the acidic region (italic), the mature peptide (bold), and the stop codon (asterisk) are3.2. Antimicrobial activity
The synthetic peptide Hs-1 was tested for its antimicrobial ac-
tivity. The MIC of the peptide Hs-1 against Gram-positive and
Gram-negative bacteria are shown in Table 1. Hs-1 displayed rela-
tively high potency (MIC 46.6 mM) against Gram-positive bacteria
and S. aureus (ATCC 33591) was the most sensitive strain
(MIC¼ 11.7 mM), but Hs-1 showed no detectable effect to any of the
tested Gram-negative bacterium. The 50% DMSO solution was not
toxic to any bacterial strains (data not shown). The Hs-1 antimi-
crobial activity and general characteristics were compared with
other antimicrobial peptides from Hypsiboas species (Table 2).
3.3. Cytolytic effect
The toxicity of Hs-1 was evaluated both in erythrocytes as in
leukocytes. In general, Hs-1 had a moderate cytolytic activity
(LC50¼ 82 mM), but had no signiﬁcant cytolytic activity in the range
of its antimicrobial activity (MIC¼ 11.7e46.6 mM). The Hs-1 showed
a greater margin of safety for S. aureus, as demonstrated for its TI
(TI ¼ 7.3), than for B. cereus (TI ¼ 3.7), B. subtilis (TI ¼ 3.7) and
L. monocytogenes (TI ¼ 1.8). The 50% DMSO solution showed no
cytotoxicity to both erythrocytes and leukocytes (Fig. 2A and B).
3.4. Structural and physicochemical properties of Hs-1
Hs-1 consists of a polypeptide chain of 20 amino acid residues
(FLPLILPSIVTALSSFLKQG). Secondary structural prediction analysis
showed that Hs-1 is structured primarily in an alpha-helix and it is
also composed of random coil and beta-turn structures (Figs. 3 and
4A). A SchiffereEdmudson projection of Hs-1 revealed a spatials semilineatus. The nucleotides are in lowercase letters and the predicted amino acid
te the positions of the nucleotides and amino acids. The putative signal peptides (solid-
indicated.
Table 2
General characteristics of antimicrobial peptides derived from Hypsiboas species.
Organism Peptide Sequence Length Mass MIC (mM) Ref.
S. aureus E. coli
H. semilineatus Hs-1 FLPLILPSIVTALSSFLKQG 20 2.144.6 11.7 ND This work
H. albopunctatus Hylin a1 IFGAILPLALGALKNLIK 18 1864.19 8 32 Castro et al., 2009
H. biobeba Hylin-b1 FIGAILPAIAGLVHGLINR 19 1945.3 ND ND Castro et al., 2005
H. biobeba Hylin-b2 FIGAILPAIAGLVGGLINR 19 1865.2 ND ND Castro et al., 2005
H. punctata Hylaseptin-P1 GILDAIKAIAKAAG 14 1311.80 6.1e8 24.4e32 Prates et al., 2004
H. raniceps Rsp-1 AWLDKLKSLGKVVGKVALGVAQNYLNPQQ 29 ND 20 5 Magalh~aes et al., 2008
H. pulchellus P1-Hp-1971 TKPTLLGLPLGAGPAAGPGKR-NH2 21 1971.1 8 16 Siano et al., 2014
H. pulchellus P2-Hp-1935 KLSPSLGPVSKGKLLAGQR-NH2 19 1935.2 66 3 Siano et al., 2014
H. pulchellus P3-Hp-1891 RLGTALPALLKTLLAGLNG-NH2 19 1891.2 17 17 Siano et al., 2014
ND-Not determined.
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the helix (Fig. 4B), conﬁrming the amphipathic character of the
helix. According to ProtParam, Hs-1 has a molecular weight of
2144.6 Da, theorical pI of 8.75, GRAVYof 1.275, and a net charge þ1.
In the thermostability screening assay, the peptide Hs-1 was ther-
mostable in temperatures up to 60 C (data not shown).3.5. TEM
To investigate the possible mechanisms of action of Hs-1, the
peptide was incubated with Staphylococcus aureus and monitoredFig. 2. Cytolytic effects of Hs-1 on human erythrocytes and leukocytes. A) Red blood
cells were treated with different concentrations of Hs-1, and its cytotoxicity was
evaluated in comparison with Triton X-100 (100% hemolysis) and saline (0% hemoly-
sis). B) Leukocytes were treated with different concentrations of Hs-1, and its cyto-
toxicity was evaluated in comparison with Triton X-100 (100% cytolysis) and Roswell
Park Memorial Institute medium (RPMI) medium (0% cytolysis). Assays were per-
formed in triplicate, and the results represent as mean ± stand error of mean (SEM).under TEM. Control treatment of S. aureus with no peptide
exhibited intact electron-dense cells with a normal shape (spher-
ical) and smooth surface (Fig. 5A and D). In contrast, bacteria
treated by Hs-1 showed altered morphology and irregular surfaces.
With 2 h of exposition to the AMP, bacteria presented damage that
was indicative of cell death, such as swelling, leakage of cellular
contents, and blebbing of the plasma membrane (Fig. 5B and C).
After 3 h of exposure, the damage cited above was more pro-
nounced and some cells collapsed as well (Fig. 5E and F). These
micrographs suggest that Hs-1 has a direct bactericidal effect,
probably for acting at the membrane level.4. Discussion
This work reports the identiﬁcation and characterization of Hs-
1, an AMP from the skin of H. semilineatus. This treefrog species is
endemic to Atlantic Forest (Frost, 2013), a rich biome present in
Brazil, and, until now, no records of AMPs derived from this species
are available. The interest in antimicrobial peptides of amphibians
belonging Hylinae subfamily has increased recently including
antimicrobial peptides from skin secretions of the genus Hypsiboas
(Prates et al., 2004; Castro et al., 2005; Magalh~aes et al., 2008;
Castro et al., 2009; Siano et al., 2014).
The cDNA cloning was the method utilized here for the
screening of AMPs. All peptides are made from precursor genes and
most of them can be cloned. As nature rarely provides enough
material for all the analysis required for proper characterization of a
peptide, molecular cloning is a fast and efﬁcient alternative for
obtaining AMPs' sequence. The deduced amino acid sequence of
the cDNA identiﬁed in this work has the same overall architecture
as that of other precursors of Hylidae's AMPs: a well-conserved N-
terminal region of approximately 50 residues encompassing the
signal peptide and an acidic propiece followed by a markedly var-
iable C-terminal domain that corresponds to the mature AMP
(Charpentier et al., 1998; T Chen et al., 2005; Nicolas et al., 2003;
Thompson et al., 2007; Vanhoye et al., 2003; Zhou et al., 2006).
The mature peptide of Hs-1 ends in a glycine residue suggesting
that this is an amide donor for C-terminal amidation during post-
translational modiﬁcation. This kind of modiﬁcation occurs
commonly in AMPs and it normally increases the antimicrobial
activity of a given peptide by increasing the overall positive charge
(Rinaldi, 2002). The Hs-1 was chemically synthesized without the
C-terminal amidation and its activity could have been
underestimated.
The antimicrobial assays suggest that Hs-1 has a selective ac-
tivity against Gram-positive bacteria, because all Gram-positive
strains tested were sensitive to it, whereas all the Gram-negative
strains were resistant. The MIC values (11e46 mM) are very good
if compared to AMPs from Hypsiboas group (Table 2) and other
Fig. 3. Three-dimensional (3D) representation of Hs-1 secondary structure. Alpha helix, random coil, and beta-turn structures are respectively in red, white, and blue. Hs-1 is
represented in different angles: lateral (left), frontal (middle), and superior (right). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
Fig. 4. Self-optimized prediction method with alignment (SOPMA) prediction and
SchiffereEdmundson projection of Hs-1. (A) The SOPMA prediction using window
with: 17, similarity threshold: 8, and number of states: 4. (B) A ShiffereEdmundson
helical wheel projection illustrating the amphipathic nature of the alpha helix. Hy-
drophobic residues are in gray circles and hydrophilic residues are in white circles.
Each amino acid residue is numbered according to their position in the primary
sequence of the peptide Hs-1.
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2012b). The selectivity of Hs-1 is a great sign for its future appli-
cation because Gram-positive bacteria account for causing majority
of the antibiotic-resistance infections (Chen et al., 2007; Rice,
2006).
The ability of a peptide to induce cell death is the result of a
complex interrelationship of factors involving conformation,
charge, hydrophobicity and amphipathicity (Giangaspero et al.,
2001). These characteristics do not impose a rigorous primary or
secondary structural organization, but the alpha-helical peptides
are among the most abundant and widespread in nature (Tossiet al., 2000). According to SOPMA prediction, 60% of the amino
acids residues of Hs-1 are structured in alpha helix and it is highly
amphipathic, as demonstrated by the SchiffereEdmundson helical
wheel projection. The amphipathicity of the helix is almost 100%; it
has only some residues (Leu4, Gln19, and Gly20) occupying sides of
opposite polarity. However, if we join the SchiffereEdmundson
helical with the SOPMA prediction, we can see that these residues
do not compose the helix indeed. Helix-stabilizing amino acid
residues, such as leucine, alanine, and lysine (Conlon et al., 2007b),
are well-represented in Hs-1, especially the apolar leucine that
balances the hydrophobic side.
The selectivity of Hs-1 to Gram-positive bacteria can be
explained for amphipathic alpha helix that predominates in Hs-1. It
has been assumed that a stabilized amphipathic alpha-helical
conformation is an absolute requirement for antimicrobial activ-
ity against Gram-positive bacteria, whereas structural re-
quirements for activity against Gram-negative bacteria are less
stringent (Giangaspero et al., 2001). Several strains of Gram-
negative bacteria are susceptible to both non-helical and scram-
bled peptides, which suggests that antimicrobial activity against
Gram-negative bacteria are mainly modulated by electrostatic in-
teractions (Dathe et al., 1997; Giangaspero et al., 2001). Hs-1 ex-
hibits one single positively charged amino acid (lysine), therefore,
this low cationicity probably limits its activity against Gram-
negative bacteria.
Hs-1 showed high similarity (54.54%) with AMPs of the Phyl-
loseptins family. Phylloseptins were characterized in the skin
secretion of Phyllomedusa azurea (Hylidae, Phyllomedusinae) and
this family comprised cationic peptides that have a primary
structure consisting of 19e21 amino acid residues (1.7e2.1 kDa)
and a broad spectrum of antimicrobial activity with low hemolytic
effect (Leite et al., 2005). The physicochemical properties of Hs-1
satisfy the requirements of the family, but its spectrum of activity
is more selective. Even at Hypsiboas antimicrobial peptides group,
Hs-1 is the only selective AMP identiﬁed until now. Recently, Siano
et al. (2014) identiﬁed twenty-three novel sequences of peptides
from skin secretions of Hypsiboas pulchellus, a treefrog that also
occurs in Brazil. From these sequences three were chemically
synthesized and characterized (P1-Hp-1971, P2-Hp-1935, P3-Hp-
1891). In contrast with Hs-1, P1-Hp-1971, P2-Hp-1935 and P3-Hp-
1891 are broad spectrum and they have good activity against E. coli,
probably due their high cationicity (þ4, þ5 and þ3 respectively).
Against S. aureus, only P1-Hp-1971 showed a better activity than
Hs-1 (8 mM versus 11.7 mM). The mass and size of Hs-1 are very
similar to H. pulchellus antimicrobial peptides, which range from
1891.2 to 1971.1 Da and 19 to 21 amino acids, but in respect to
structure Hs-1 is more similar to P3-Hp-1891 that adopts an
amphipatic helical structure in the presence of 2,2,2-
triﬂuoroethanol and anionic liposomes. In fact, a blast
Fig. 5. Ultrastructure of Staphylococcus aureus treated with Hs-1. Bacteria were exposed to 200 mg/mL of Hs-1 for 2 h (BeC) and 3 h (EeF). Control bacteria were not exposed to the
peptide (A, D). The scale bar is represented.
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unlike of P1-Hp-1971 and P2-Hp-1935 that shows no signiﬁcant
similarity. Likewise, comparing Hs-1 to others AMPs from Hyp-
siboas spp. it only has similarity with Hylin a1. For now, Hs-1 is the
only AMP representative of H. semilineatus (Hylidae, Hylinae).
TEM showed that Hs-1 has a direct antibacterial killing and that
the target site is the cytoplasmic membrane. This physical integrity
of the lipid bilayer is disrupted, and many cellular damage can be
visualized. This is in agreement with the mode of action proposed
and observed for the vast majority of anurans AMPs (Hou et al.,
2011; Wang et al., 2012a).
Despite the impact of antimicrobial activity, the toxicity tests are
a critical step for the ranking of a new peptide as a potential ther-
apeutic agent. Host toxicity is preponderantly evaluated in terms of
hemolytic activity but the susceptibility of erythrocytes is not
necessarily extendable to other animal cells (Tossi et al., 2000). In
this context, we tested Hs-1 in erythrocytes and in nucleated leu-
kocytes. Hs-1did not exhibit a signiﬁcant cytolytic activity in the
range of MIC, but we observed that the LC50 values were close to
MICs indicating a poor TI for Bacillus spp. and Listeria spp. On the
other hand, Hs-1 showed a high TI for Staphylococcus aureus
(TI ¼ 7.3). The TI is an important parameter for the characterization
and optimization of the safety and efﬁcacy of a drug candidate
(Muller and Milton, 2012).
World Health Organization (WHO) recognizes antimicrobial
resistance as a growing global health threat and also considers,
among other factors, that the evolution of this resistance is asso-
ciated with the dearth of new antimicrobial Agents in the devel-
opment pipeline (WHO, 2012). Here, we have identiﬁed and
characterized Hs-1, a selective AMP that presents a great cidal ac-
tivity against Gram-positive bacteria and that also has a preferential
afﬁnity for the multidrug-resistant S. aureus ATCC 33591. Predom-
inantly structured as an amphipathic alpha helix, Hs-1 is the ﬁrst
AMP reported from H. semilineatus and may be used as a template
for the development of alternative therapeutic agents intended for
many purposes, including treatment of nosocomial infections
caused by MRSA, preservation and conditioning of food (with afocus on B. ereus infection) and treatment of chronic sources of
infection such as bacterial bioﬁlms.
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